Key to symbols
The medicine should be initiated by, or on the advice of a specialist, but is suitable for continuation by a GP
The medicine should only be used and prescribed by a specialist
Indicates the preferred choice within a class or group of medicines
3. Respiratory system
3.3. Cromoglicate and related therapy, leukotriene receptor antagonists, and phosphodiesterase type-4 inh
3.3.1. Cromoglicate and related therapy
3.3.2. Leukotriene receptor antagonists
Preferred List
MONTELUKAST
Restrictions:
Use for seasonal allergic rhinitis was not accepted by SMC and this indication is non-Formulary.
The MHRA has issued advise for healthcare professionals regarding risks of neuropsychiatric reactions for montelukast. For further information click here.
Prescribing Notes:
Not currently licensed for use in COPD